TheProfitWatch

APLS - Apellis Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
23.5 1.74 (7.4%) --- --- --- 0.23 (0.98%) 1.24 (5.17%) --- 0.23 (0.98%)

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.33
Diluted EPS:
-0.33
Basic P/E:
-76.4848
Diluted P/E:
-76.4848
RSI(14) 1m:
57.79
VWAP:
25.21
RVol:
0.9472

Events

Period Kind Movement Occurred At
1m Price decrease 1m 24.56 -0.3 (-1.21%) Oct 15 09:36
1m Price increase 1m 24.96 +0.41 (+1.67%) Oct 15 09:32
10m Price increase 10m 24.96 +0.96 (+4.0%) Oct 15 09:32
60m Price increase 60m 24.96 +1.2 (+5.05%) Oct 15 09:32
1m Price increase 1m 24.55 +0.56 (+2.33%) Oct 15 09:31

Related News